wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37751530-03E02E15-2CD9-4F0F-A7DE-B0F0D4AE7081
Q37751530-03E02E15-2CD9-4F0F-A7DE-B0F0D4AE7081
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37751530-03E02E15-2CD9-4F0F-A7DE-B0F0D4AE7081
Molecular basis for therapy resistance.
P2860
Q37751530-03E02E15-2CD9-4F0F-A7DE-B0F0D4AE7081
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37751530-03E02E15-2CD9-4F0F-A7DE-B0F0D4AE7081
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a3cf2efd1dc3dfeb4900dd89204ef45927b71c7
P2860
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer